Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q2 2020 Earnings Conference Call August 13, 2020 4:30 PM ET Company Participants Matthew Plavan - President & CEO Pamela Haley - CFO Randy Shultz - Chief Technology Officer Conference Call Participants Ben Klieve - National Securities Corporation Steven Ralston - Zachs Robert Smith - Center for Performance Investing Operator Good afternoon, and welcome to Arcadia Biosciences Second Quarter 2020 Earnings Conference Call. Today's presenters will be Matt Plavan, Presiden ...

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2020 Results Earnings Conference Call May 13, 2020 4:30 PM ET Company Participants Matthew Plavan - President & CEO Sarah Reiter - Chief Commercial Officer Pamela Haley - CFO Conference Call Participants Ben Klieve - National Securities Corporation Steven Ralston - Zachs Robert Smith - Center for Performance Investing Operator Good afternoon, and welcome to Arcadia Biosciences First Quarter 2020 Earnings Conference Call. Today's presenters will be Matt Plavan, Pres ...

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2019 Earnings Conference Call March 25, 2020 4:30 PM ET Company Participants Matthew Plavan - President & CEO Sarah Reiter - Chief Commercial Officer Pamela Haley - CFO Conference Call Participants Raghuram Selvaraju - H.C. Wainwright & Co. Benjamin Klieve - National Securities Corporation Operator Good afternoon, and welcome to Arcadia Biosciences year-end 2019 Earnings Conference Call. Today's presenters will be Matt Plavan, President and CEO; Sarah Reiter, Chief ...

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q3 2019 Results Conference Call November 6, 2019 4:30 PM ET Company Participants Matt Plavan - President and CEO Sarah Reiter - Chief Commercial Officer Pam Haley - Chief Financial Officer Conference Call Participants Ben Klieve - National Securities Brian Marckx - Zacks Investment Operator Good afternoon, and welcome to the Arcadia Biosciences Third Quarter 2019 Earnings Conference Call. Today's presenters will be Matt Plavan, President and CEO; Sarah Reiter, Chief C ...

Q3 2019 Financial Results and Business Highlights Supplemental Slides November 6, 2019 Forward-looking statements • "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements about the company and its products, including statements relating to components of the company's long-term financial success; the company's traits, commercial products, and collaborations; the company's ability to manage the regulatory processes for its trai ...

Arcadia Biosciences Investor Presentation September 2019 Forward-looking statements • "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements about the company and its products, including statements relating to components of the company's long-term financial success; the company's traits, commercial products, and collaborations; the company's ability to manage the regulatory processes for its traits and commercial products; th ...

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q2 2019 Earnings Conference Call August 14, 2019 4:30 PM ET Company Participants Rajendra Ketkar - President and Chief Executive Officer Matthew Plavan - CFO of Arcadia and President of Arcadia Specialty Genomics Sarah Reiter - Chief Commercial Officer Conference Call Participants Raghuram Selvaraju - H.C. Wainwright Ben Klieve - National Securities Robert Smith - Center for Performance Investing Operator Good afternoon, and welcome to Arcadia BiosciencesÂ' Second Qua ...

Q2 2019 Financial Results and Business Highlights August 14, 2019 Forward-looking statements • "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements about the company and its products, including statements relating to components of the company's long-term financial success; the company's traits, commercial products, and collaborations; the company's ability to manage the regulatory processes for its traits and commercial pro ...

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2019 Results Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Rajendra Ketkar - President and CEO Matthew Plavan - CFO Conference Call Participants Benjamin Klieve - National Securities Corporation Robert Smith - Center of Performance Operator Good afternoon, and welcome to Arcadia BiosciencesÂ' First Quarter 2019 Earnings Conference Call. Today's presenters will be Raj Ketkar, President and CEO; and Matt Plavan, CFO and President of Arcadia Spe ...

| --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|---------------------------|-------|-------|-------| | | | | | | | | | | | | | | Q1 2019 Financial Results | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | and Business Highlights | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Forward-looking statements • "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This presentati ...